Literature DB >> 16151757

[Therapy of the "aging male"].

T Diemer1, E W Hauck, V Rohde, W Weidner.   

Abstract

Serum testosterone levels decline in men with increasing age. Late-onset hypogonadism with its characteristic symptoms can occur in men as they age. Typical symptoms of late-onset hypogonadism are decreased libido and sexual function, osteoporosis, altered distribution of body fat, overall reduction in physical strength, and alterations in general mood. Late-onset hypogonadism can be treated with testosterone, and different forms of testosterone have become available for this indication. The aim of testosterone replacement therapy is to produce serum testosterone levels within the physiological range avoiding levels above and below this range. Although hormone replacement therapy has become accepted in aging males, careful consideration of the indications and therapy monitoring are still required since there are major concerns about the long-term outcome of this therapy and particularly its effects on the prostate gland.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151757     DOI: 10.1007/s00120-005-0906-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  32 in total

Review 1.  Efficiency of spermatogenesis: a comparative approach.

Authors:  L Johnson; D D Varner; M E Roberts; T L Smith; G E Keillor; W L Scrutchfield
Journal:  Anim Reprod Sci       Date:  2000-07-02       Impact factor: 2.145

Review 2.  Andropause: hormone replacement therapy in the ageing male.

Authors:  F H Comhaire
Journal:  Eur Urol       Date:  2000-12       Impact factor: 20.096

3.  Role of the hypothalamo-pituitary function in the hypoandrogenism of healthy aging.

Authors:  A Vermeulen; J M Kaufman
Journal:  J Clin Endocrinol Metab       Date:  1992-09       Impact factor: 5.958

4.  Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations.

Authors:  E Nieschlag; R Swerdloff; H M Behre; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; J E Morley; C Schulman; C Wang; W Weidner; F C W Wu
Journal:  Int J Androl       Date:  2005-06

5.  Apoptosis as a mechanism of germ cell loss in elderly men.

Authors:  M H Brinkworth; G F Weinbauer; M Bergmann; E Nieschlag
Journal:  Int J Androl       Date:  1997-08

Review 6.  Aging of the male reproductive system.

Authors:  M Hermann; G Untergasser; H Rumpold; P Berger
Journal:  Exp Gerontol       Date:  2000-12       Impact factor: 4.032

7.  Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer.

Authors:  M Ribeiro; P Ruff; G Falkson
Journal:  Am J Clin Oncol       Date:  1997-12       Impact factor: 2.339

8.  Does age-associated reduced Leydig cell testosterone production in Brown Norway rats result from under-stimulation by luteinizing hormone?

Authors:  F W Grzywacz; H Chen; J Allegretti; B R Zirkin
Journal:  J Androl       Date:  1998 Sep-Oct

Review 9.  Ageing of the hypothalamo-pituitary-testicular axis in men.

Authors:  A Vermeulen; J M Kaufman
Journal:  Horm Res       Date:  1995

10.  Prostate-specific antigen changes in hypogonadal men treated with testosterone replacement.

Authors:  Robert E Gerstenbluth; Prakash N Maniam; Eric W Corty; Allen D Seftel
Journal:  J Androl       Date:  2002 Nov-Dec
View more
  1 in total

1.  [Prevention of osteoporosis--important for the urologist?].

Authors:  G Lümmen; H Rübben; T Schneider; H Sperling
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.